{"id":"F2007B00632","name":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 16 of 2004)","slug":"national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-16-of-2004","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":62424,"registerId":"commonwealth-F2007B00632-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 16 of 2004)","content":"COMMONWEALTH OF AUSTRALIA\n\nNational Health Act 1953\n\nPHARMACEUTICAL BENEFITS\n\nDECLARATION UNDER SUBSECTION 85(2AA)\n\nNo. PB 16 of 2004\n\nI, JOAN CORBETT, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Ageing and Delegate of the Minister for Health and Ageing, having in accordance with subsection 85(2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85(2AA) of the National Health Act 1953 hereby make the following Declaration:\n\n1. This Declaration commences on 1 December 2004.\n\n2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.\n\nTHE SCHEDULE\n\nAmmonium Chloride\n\nBendrofluazide\n\nOmeprazole Magnesium and Clarithromycin and Amoxycillin Trihydrate\n\nRofecoxib\n\nSodium Nitroprusside\n\nTimolol Maleate with Pilocarpine Hydrochloride\n\nDated this seventeenth day of November 2004.\n\nJOAN CORBETT\n\nAssistant Secretary\n\nPharmaceutical Benefits Branch\n\nDepartment of Health and Ageing\n\nDelegate of the Minister for Health and Ageing","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":1851},"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"This instrument performs exactly the narrow administrative function authorised by section 85(2AA) of the National Health Act 1953: removing specified pharmaceutical items from the PBS. There is no expansion beyond the original legislative purpose."},"complexity_factors":["Single operative clause with direct effect (no conditional logic)","Only 6 items listed in the Schedule","No defined terms or interpretation provisions","Minimal cross-referencing (only to sections 85(2AA) and 85(2AB) of parent Act)","No exceptions, exemptions, or transitional provisions"],"plain_english_summary":"This declaration removes six specific medicines from Australia’s Pharmaceutical Benefits Scheme effective 1 December 2004, so those drugs are no longer government-subsidised. Patients who relied on PBS prescriptions for them must either switch to alternatives or pay the full pharmacy price (or use private cover).\n\nThe change follows a Pharmaceutical Benefits Advisory Committee review finding cheaper, safer, or more cost‑effective options, prompting subsidy withdrawal."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-16-of-2004","history":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-16-of-2004/history","analysis":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-16-of-2004/analysis","conflicts":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-16-of-2004/conflicts","importantCases":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-16-of-2004/important-cases","documents":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-16-of-2004/documents"}}